$252 Million is the total value of Tri Locum Partners LP's 30 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 106.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $28,645,000 | +18.7% | 261,500 | +1.4% | 11.38% | +44.1% |
| BAX | New | BAXTER INTL INC | $25,126,000 | – | 312,400 | +100.0% | 9.98% | – |
| WBA | Sell | WALGREENS BOOTS ALLIANCE INCcall | $16,468,000 | -68.7% | 350,000 | -65.0% | 6.54% | -62.0% |
| SGEN | New | SEAGEN INC | $16,353,000 | – | 96,307 | +100.0% | 6.50% | – |
| WBA | Sell | WALGREENS BOOTS ALLIANCE INC | $14,719,000 | -34.3% | 312,847 | -26.5% | 5.85% | -20.2% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $13,911,000 | +178.3% | 122,880 | +154.6% | 5.53% | +237.9% |
| MRK | New | MERCK & CO INC | $13,652,000 | – | 181,765 | +100.0% | 5.42% | – |
| SKIN | New | THE BEAUTY HEALTH COMPANY | $13,105,000 | – | 504,606 | +100.0% | 5.21% | – |
| MDT | Sell | MEDTRONIC PLC | $13,045,000 | -43.1% | 104,070 | -43.6% | 5.18% | -30.9% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $12,490,000 | – | 135,055 | +100.0% | 4.96% | – |
| MRK | New | MERCK & CO INCcall | $11,304,000 | – | 150,500 | +100.0% | 4.49% | – |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $8,518,000 | – | 168,467 | +100.0% | 3.38% | – |
| REGN | Sell | REGENERON PHARMACEUTICALS | $8,442,000 | -80.0% | 13,950 | -81.6% | 3.36% | -75.7% |
| LPTX | New | LEAP THERAPEUTICS INC | $7,261,000 | – | 1,810,672 | +100.0% | 2.88% | – |
| EGRX | Buy | EAGLE PHARMACEUTICALS INC | $6,833,000 | +68.2% | 122,503 | +29.1% | 2.72% | +104.1% |
| ISEE | Buy | IVERIC BIO INC | $6,134,000 | +903.9% | 377,708 | +290.1% | 2.44% | +1119.0% |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $6,064,000 | – | 32,851 | +100.0% | 2.41% | – |
| BLU | Buy | BELLUS HEALTH INC NEW | $5,974,000 | +411.5% | 972,997 | +159.1% | 2.37% | +521.5% |
| CCXI | New | CHEMOCENTRYX INCcall | $4,726,000 | – | 276,400 | +100.0% | 1.88% | – |
| XENE | New | XENON PHARMACEUTICALS INC | $4,036,000 | – | 264,134 | +100.0% | 1.60% | – |
| NVAX | New | NOVAVAX INCcall | $4,001,000 | – | 19,300 | +100.0% | 1.59% | – |
| CYCC | Buy | CYCLACEL PHARMACEUTICALS INC | $2,756,000 | +48.6% | 522,943 | +66.9% | 1.10% | +80.4% |
| LSAQ | Sell | LIFESCI ACQUISITION II CORP | $2,580,000 | -4.4% | 263,289 | -2.4% | 1.02% | +16.1% |
| BNTX | New | BIONTECH SEsponsored ads | $1,503,000 | – | 5,506 | +100.0% | 0.60% | – |
| AVDL | Sell | AVADEL PHARMACEUTICALS PLCsponsored adr | $1,454,000 | -31.2% | 148,355 | -52.7% | 0.58% | -16.4% |
| FEMY | Buy | FEMASYS INC | $1,313,000 | -14.2% | 190,600 | +1.0% | 0.52% | +4.2% |
| TBPH | New | THERAVANCE BIOPHARMA INC | $956,000 | – | 129,192 | +100.0% | 0.38% | – |
| CCXI | New | CHEMOCENTRYX INC | $274,000 | – | 16,045 | +100.0% | 0.11% | – |
| ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -6,408 | -100.0% | -0.63% | – |
| MREO | Exit | MEREO BIOPHARMA GROUP PLCads | $0 | – | -1,253,729 | -100.0% | -1.30% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDcall | $0 | – | -445,900 | -100.0% | -1.44% | – |
| MRNA | Exit | MODERNA INC | $0 | – | -19,193 | -100.0% | -1.48% | – |
| FLGT | Exit | FULGENT GENETICS INCcall | $0 | – | -50,000 | -100.0% | -1.51% | – |
| ENDP | Exit | ENDO INTL PLCcall | $0 | – | -1,048,100 | -100.0% | -1.60% | – |
| HUM | Exit | HUMANA INC | $0 | – | -11,305 | -100.0% | -1.64% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -175,305 | -100.0% | -1.92% | – |
| ITCI | Exit | INTRA CELLULAR THERAPIES INC | $0 | – | -150,783 | -100.0% | -2.02% | – |
| EOLS | Exit | EVOLUS INC | $0 | – | -496,826 | -100.0% | -2.06% | – |
| PFE | Exit | PFIZER INC | $0 | – | -202,692 | -100.0% | -2.60% | – |
| ALDX | Exit | ALDEYRA THERAPEUTICS INC | $0 | – | -818,025 | -100.0% | -3.03% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -50,699 | -100.0% | -3.93% | – |
| JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -85,596 | -100.0% | -4.62% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -341,650 | -100.0% | -5.02% | – |
| JAZZ | Exit | JAZZ PHARMACEUTICALS PLC | $0 | – | -89,370 | -100.0% | -5.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FEMASYS INC | 10 | Q3 2023 | 0.5% |
| REGENERON PHARMACEUTICALS | 9 | Q3 2023 | 13.8% |
| LILLY ELI & CO | 9 | Q2 2023 | 9.5% |
| X4 PHARMACEUTICALS INC | 8 | Q3 2023 | 3.0% |
| XENON PHARMACEUTICALS INC | 8 | Q3 2023 | 2.4% |
| ARGENX SE | 7 | Q3 2023 | 12.8% |
| STEVANATO GROUP S P A | 7 | Q2 2023 | 5.8% |
| PROTAGONIST THERAPEUTICS INC | 7 | Q2 2023 | 7.1% |
| AVADEL PHARMACEUTICALS PLC | 7 | Q3 2023 | 6.4% |
| BELLUS HEALTH INC NEW | 7 | Q3 2022 | 4.3% |
View Tri Locum Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-27 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Tri Locum Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.